As­traZeneca and Glax­o­SmithK­line come to a peace­ful set­tle­ment of their tug of war over Luke Miels

It looks like Luke Miels “gar­den­ing leave” will run through the sum­mer be­fore he bids one fi­nal farewell to As­traZeneca and moves over to Glax­o­SmithK­line as phar­ma chief.

The two UK phar­ma gi­ants qui­et­ly duked it out over Miels af­ter Glax­o­SmithK­line an­nounced the move. As­traZeneca boxed him up with his con­tract, su­ing him over the move, but GSK says to­day that Miels will now start his new job — free of any old strings — as phar­ma pres­i­dent on Sep­tem­ber 4.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.